Lion Point Capital’s Mersana Therapeutics MRSN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$191K	Hold	25,760	–	–	1.29%	17
2025 Q1	$222K	Buy	+25,760	New	+$222K	1.41%	19
2023 Q3	–	Hold	0	–	–	–	30
2023 Q2	–	Sell	-16,365	Closed	-$1.68M	–	29
2023 Q1	$1.68M	Buy	+16,365	New	+$1.68M	0.69%	16